LBS Healthcare Conference 2023

Day 1- 29th March 2023

Dame Barbara Hakin

Health Advisory Consultant and former National Director NHS

Dame Barbara has a unique blend of clinical and managerial experience in the NHS, twenty years as a doctor and twenty in management at the most senior level. She was widely known and respected as an experienced system leader.

Having been both a PCT and SHA Chief Executive, she was latterly Deputy Chief Executive and Chief Operating Officer of NHS England, responsible for overseeing all national performance – oversight of CCGs through the regional teams as well as specialised commissioning and all primary care commissioning and contracting. She was recognised as one of the most influential individuals in the NHS, working closely with Ministers and key decision makers for almost two decades.

In her early career she spent twenty years as a General Practitioner, moving on to be the Clinical Chair of Bradford PCG then Chief Executive of the PCT. During this time she was instrumental in many initiatives which transformed the way care was delivered. Many of these initiatives had an influence on national policy.

Since her retirement from the NHS she provides strategic advice to a number of UK and international commercial companies who provide services to the health and care system. She has championed the cause of the full range of expertise the independent sector can bring, including the direct provision of care and the use of data and analytics as well as supporting innovations and new technologies into the market.

Panel | Innovation and Venture Capital
29th March 5:30pm-6:30pm BST

Dr. Marek Tyl (Moderator)

Scientific Advisor, Innovation Hub Lead

Georgina Askeland

Senior Investment Associate
Hadean Ventures

Jack O’Meara

Ochre Bio

Michaël Niddam

Co-Founder and CEO
Kamet Ventures

Dr. Anushka Patchava

Deputy Chief Medical Officer at Vitality

Anushka has over 10+ years clinical and corporate experience, devising and implementing tactical, data-driven and technology-enabled strategies to drive profitability and growth, across pharmaceutical, digital health, medical device and health insurance sectors. She has practiced as a physician in the UK and US, and has lived and/or worked in Europe, Middle East, America and the Asia-Pacific markets. In her current role as Deputy Chief Medical Officer at Vitality, Anushka is focused on managing clinical risk and delivering high quality care through innovative clinical pathways to drive robust health outcomes. Outside of the day-job, Anushka serves as an Expert Advisor to the United Nations (CEFACT) in Artificial Intelligence and Blockchain and can often be found training for the next regional power-lifting competition or obstacle course endurance race.

Panel | The Inflation Reduction Act's Impact on Pharma
29th March 7:30pm-8:15pm BST

Prof. Nicos Savva (Moderator)

Professor of Management Science and Operations, London Business School

Stephen Sutherland

Managing Director & Partner

Antonio Iervolino

Putnam Associates

A/Prof. Aris Angelis

Associate Professor of Health Economics LSHTM

Day 2- 30th March 2023

Amy Landucci

Chief Technology and Digital Officer at Haleon

Amy is Haleon’s Chief Digital and Technology Officer, a role she’s held since 2021, while the business was still part of GSK.

Prior to joining GSK in 2017, as Chief Information Officer for Consumer Healthcare, Amy spent more than a decade at Novartis, where she was most recently the Global Head of Digital Medicines. She was responsible for defining and delivering the “beyond the pill” strategy and solutions to accelerate Novartis’s entrance into Digital Medicines. Prior to this role, Amy was Chief Information Officer for the Novartis OTC Division.

Amy previously served on the Board of Directors for Healthy Women, the leading independent, non-profit health information source for women in the US with a mission to educate and empower women to make informed health choices for themselves and their families.

David Pyott | Pursuing innovation in the healthcare and pharmaceutical markets

Incoming Governing Body Chair for London Business School, Board Member of Philips, Alnylam Pharmaceuticals, BioMarin Pharmaceutical and Former Chairman and CEO at Allergan

Dr. David Pyott is an accomplished international pharmaceutical executive with more than 30 years of leadership and management experience with particular expertise in organizational scaling.

Most recently, he served as Chairman and Chief Executive Officer of Allergan, Inc. where, over 17 years in this role, he transformed the company from a small eye care business with $1 billion in annual sales into a global specialty pharmaceutical and medical device company with 2014 annual sales of over $7 billion and more than 10,000 employees. Before that, he served as Head of the Novartis Nutrition Division and served as a member of the Executive Committee of Novartis AG.

In addition to Pliant, David currently serves as a member of the Board of Directors of Alnylam Pharmaceuticals and BioMarin Pharmaceutical and is a member of the Supervisory Board of Royal Philips in the Netherlands, a public diversified health technology company. David will also be the Governing Body Chair of London Business School from 1 May 2023. 

David also serves as Deputy Chairman of the Governing Board of the London Business School, President of the Ophthalmology Foundation, President of the Advisory Board of the American Academy of Ophthalmology and is a member of the Executive Committee and Trustee of the California Institute of Technology.

David holds a Diploma in International and European Law from the Europa Institute at the University of Amsterdam, an Honorary Degree in Medicine and a Master of Arts degree from the University of Edinburgh, and a Master of Business Administration degree from the London Business School.

Panel | BigTech and Healthcare
30th March 7:30pm-8:15pm BST

Prof. Kamalini Ramdas- Moderator

Professor of Management Science and Operations, London Business School

Kira Levy

Head of Healthcare UK
Amazon Web Services

Dr. Vishaal Virani

Head of UK Health

Julius Neiser

BCG X.Ventures Managing Director and Partner

Ilya Yuffa

Executive Vice President and President, Lilly International

With a tenure of more than 25 years at Lilly, Ilya most recently served as senior vice president of Lilly Bio-Medicines and previously vice president of U.S. Diabetes for Lilly USA from 2018 to 2020.

Since joining Lilly in 1996 as a financial analyst, Ilya has held a number of positions in finance, business development, sales and general management. He served as managing director of the Israeli affiliate from 2008 until 2011, senior sales director of osteoporosis from 2011 until 2013, and held senior leadership positions within six sigma and ethics and compliance from 2013 until 2017. In 2017, Ilya was named president and general manager of Lilly’s Italy Hub, leading the commercialization of the entire Lilly portfolio in more than 25 countries.

Born in St. Petersburg, Russia, Ilya grew up in Colorado. His career has taken him around the world, and he has lived and worked in the United Kingdom, Czech Republic, Italy and Israel.

Ilya earned a Bachelor of Science degree from Tulane University in 1996, and a Master of Business Administration degree from the London Business School in 2002.

Ilya is a member of the Board of Directors for the U.S.-Japan Business Council and the Advisory Board of the U.S. Chamber of Commerce China Center. He also serves as a board member for the European Federation of Pharmaceutical Industries and the management committee of Business Equity for Indy.